1989
DOI: 10.1016/0968-0004(89)90013-3
|View full text |Cite
|
Sign up to set email alerts
|

MHC class II invariant chains in antigen processing and presentation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0
1

Year Published

1990
1990
2013
2013

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(13 citation statements)
references
References 23 publications
0
12
0
1
Order By: Relevance
“…Then, the translated proteins of Ii were detected by flow cytometry analysis, and the specificity of those antibodies was confirmed by immunoprecipitation. Polyacrylamide gel electrophoresis of the immunoprecipitated samples revealed the presence of the p33 and p41 isoforms of Ii, previously described on APCs (Strubin et al 1986;O'Sullivan et al 1987;Koch et al 1989), and the coassociated MHC class II molecules. The electrophoretic mobility of these proteins differs within cell types, suggesting differences in molecular weight.…”
Section: Discussionmentioning
confidence: 99%
“…Then, the translated proteins of Ii were detected by flow cytometry analysis, and the specificity of those antibodies was confirmed by immunoprecipitation. Polyacrylamide gel electrophoresis of the immunoprecipitated samples revealed the presence of the p33 and p41 isoforms of Ii, previously described on APCs (Strubin et al 1986;O'Sullivan et al 1987;Koch et al 1989), and the coassociated MHC class II molecules. The electrophoretic mobility of these proteins differs within cell types, suggesting differences in molecular weight.…”
Section: Discussionmentioning
confidence: 99%
“…Because of alternative splicing, mice and humans also express p41 and p43, respectively Koch et al 1987;O'Sullivan et al 1987). The additional sequence in their exoplasmic domain has protease inhibitory ac-tivity especially to the cysteine protease cathepsin L (Koch et al 1989;Bevec et al 1996;Mihelič et al 2008) and influences the antigen-processing capacity of endosomes (Peterson and Miller 1992). In humans, but not in mice, an alternative start codon provides two additional Ii isoforms, p35 and p45, carrying a cytoplasmic extension that is shielded only after correct folding of the MHCII -Ii complex and, when exposed, serves as an ER-retention motif.…”
Section: Biosynthesis Of Mhciimentioning
confidence: 99%
“…The high rate of class II synthesis gives immature DCs the possibility to charge a large number of class II molecules with immunogenic peptides. The concomitant abundant synthesis of Ii, which is also involved in antigen processing (22,26), would ensure that the peptide binding groove (35,36) of all de novo-synthesized class II molecules is protected until the class II/Ii complex reaches the organelle where it encounters the antigen, presumably the acidic endosome (11,12). The unusually high degree of I, sialylation in fresh LCs gives these polypeptides a strong negative charge.…”
Section: Biochemistry Of Class II and Ii Molecules Of Immaturementioning
confidence: 99%